tiprankstipranks
XORTX Therapeutics Inc (XRTX)
NASDAQ:XRTX
US Market

XORTX Therapeutics Inc (XRTX) Financial Statements

Compare
56 Followers

XORTX Therapeutics Inc Financial Overview

XORTX Therapeutics Inc's market cap is currently C$3.28M. The company's EPS TTM is $-0.035; its P/E ratio is ―; XORTX Therapeutics Inc is scheduled to report earnings on April 30, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit-$ -75.27K$ -17.88K$ -20.44K$ -19.90K
Operating Income---$ -1.30M$ -565.97K
EBITDA-$ -9.41M$ -1.63M$ -1.25M$ -572.47K
Net Income---$ -1.28M$ -629.58K
Balance Sheet
Cash & Short-Term Investments$ 3.45M$ 10.41M$ 14.79M$ 171.27K$ 58.61K
Total Assets$ 5.47M$ 12.34M$ 17.28M$ 2.29M$ 1.09M
Total Debt$ 11.51K$ 77.44K$ 0.00$ 0.00$ 50.81K
Net Debt$ -3.44M$ -10.33M$ -14.79M$ -171.27K$ -7.80K
Total Liabilities$ 825.94K$ 5.37M$ 4.16M$ 1.03M$ 1.30M
Stockholders' Equity$ 4.64M$ 6.97M$ 13.13M$ 1.26M$ -211.72K
Cash Flow
Free Cash Flow$ -6.63M--$ -742.75K$ -256.62K
Operating Cash Flow$ -6.58M--$ -728.40K$ -249.58K
Investing Cash Flow$ -46.36K--$ -14.35K$ -7.04K
Financing Cash Flow$ -361.04K$ 4.74M$ 19.18M$ 855.41K$ 55.21K
Currency in USD

XORTX Therapeutics Inc Earnings and Revenue History

XORTX Therapeutics Inc Debt to Assets

XORTX Therapeutics Inc Cash Flow

XORTX Therapeutics Inc Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis